Related Experiment Video
Updated: Oct 3, 2025
Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
Published on: November 13, 2012
Qa-1b functions as an oncogenic factor in mouse melanoma cells
Xiang Guo1, Yi Fang2, Congfang Guo3
1College of Veterinary Medicine, Shanxi Agricultural University, Taigu, China.
Background:
Malignant melanoma is one kind of rare cancer in human and animals, which occurs not only in skin but also in the mucous membranes of the nose, mouth, anus, digestive tract, and in the uvea (choroid) of the eye. In order to develop therapies, a better understanding of the genetic landscape and signal pathways are needed. Numerous studies highlighted the importance of NKG2A-HLA-E in tumor immunotherapy, but the function and mechanism of HLA-E in tumor cells have seldom been studied alone. The statistical analyses from publicly available database Oncomine and The Cancer Genome Atlas (TCGA) showed that HLA-E is highly expressed in melanoma compared to non-transformed counterparts. In addition, melanoma patients with HLA-E high expression had a worse OS rate than the patients with low expression. These data indicate the importance of HLA-E in human melanoma. Qa-1b is the homolog of HLA-E in mouse.
Objective:
To investigate the function and mechanism of Qa-1b in mouse melanoma.
Methods:
Mouse melanoma cell line B16-F10 and allogenic melanoma model were used to investigate the function and mechanism of Qa-1b in melanoma.
Results:
Qa-1b was highly expressed in B16-F10 compared with normal mouse epidermal cells. Qa-1b knockdown inhibited B16-F10 cell proliferation and migration in vitro and allogenic melanoma process in vivo. Furthermore, Qa-1b knockdown promoted cell cycle arrest at G0/G1 phase and cell apoptosis through Ras-Raf-MAPK signal pathway.
Conclusion:
Qa-1b functions as an oncogenic factor and it can be used as a new therapeutic target in melanoma.
Insights
The mouse homolog of HLA-E, Qa-1b, is highly expressed in melanoma and drives tumor growth. Inhibiting Qa-1b may offer a new therapeutic strategy for melanoma treatment.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Malignant melanoma, a rare cancer, affects various tissues and requires better understanding of its genetic landscape for therapy.
- The NKG2A-HLA-E pathway is crucial in tumor immunotherapy, yet HLA-E's specific role in tumor cells remains understudied.
- High HLA-E expression correlates with poorer survival rates in human melanoma patients, indicating its significance.
Purpose of the Study:
- To investigate the function and mechanism of Qa-1b, the mouse homolog of HLA-E, in mouse melanoma.
- To explore Qa-1b's role in melanoma cell proliferation, migration, and the cell cycle.
Main Methods:
- Utilized the mouse melanoma cell line B16-F10 for in vitro studies.
- Employed an allogeneic melanoma model in mice for in vivo investigations.
- Performed Qa-1b knockdown experiments to assess its functional impact.
Main Results:
- Qa-1b exhibited high expression in B16-F10 cells compared to normal mouse epidermal cells.
- Knockdown of Qa-1b suppressed melanoma cell proliferation and migration in vitro and tumor progression in vivo.
- Qa-1b inhibition induced cell cycle arrest at the G0/G1 phase and promoted apoptosis via the Ras-Raf-MAPK pathway.
Conclusions:
- Qa-1b acts as an oncogenic factor in melanoma.
- Qa-1b represents a potential novel therapeutic target for melanoma treatment.
More Related Videos
06:09Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:23Abnormal Proliferation
01:06Induced Pluripotent Stem Cells
Somatic...